Plasma GABA predicts acute response to divalproex in mania

Frederick Petty, A. John Rush, John M. Davis, Joseph R. Calabrese, Susan E. Kimmel, Gerald L. Kramer, Joyce G. Small, Marvin J. Miller, Alan E. Swann, Paul J. Orsulak, Molly E. Blake, Charles L. Bowden

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Bipolar I, manic phase inpatients were treated with divalproex sodium, lithium, or placebo in a previously reported parallel group multicenter, double-blind, randomized, controlled acute phase treatment trial, Plasma concentrations of gamma aminobutyric acid (GABA) were measured before and after treatment. Higher pretreatment plasma GABA levels were significantly (p = .04) related to a better clinical response to divalproex (n = 19). Pretreatment plasma GABA levels did not correlate with response to either lithium (n = 13) or placebo (n = 31). Following treatment with divalproex sodium, plasma GABA levels decreased significantly (p <.05), compared to placebo. Pretreatment plasma GABA levels were not related to overall severity of manic symptoms. Plasma GABA may predict response to pharmacologic agents acting on the GABA system.

Original languageEnglish (US)
Pages (from-to)278-284
Number of pages7
JournalBiological Psychiatry
Volume39
Issue number4
DOIs
StatePublished - Feb 15 1996

Fingerprint

Valproic Acid
Bipolar Disorder
gamma-Aminobutyric Acid
Placebos
Lithium
Inpatients
Therapeutics

Keywords

  • Bipolar disorder
  • Divalproex
  • GABA
  • Lithium
  • Mania
  • Response prediction
  • Valproic acid

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Petty, F., Rush, A. J., Davis, J. M., Calabrese, J. R., Kimmel, S. E., Kramer, G. L., ... Bowden, C. L. (1996). Plasma GABA predicts acute response to divalproex in mania. Biological Psychiatry, 39(4), 278-284. https://doi.org/10.1016/0006-3223(95)00141-7

Plasma GABA predicts acute response to divalproex in mania. / Petty, Frederick; Rush, A. John; Davis, John M.; Calabrese, Joseph R.; Kimmel, Susan E.; Kramer, Gerald L.; Small, Joyce G.; Miller, Marvin J.; Swann, Alan E.; Orsulak, Paul J.; Blake, Molly E.; Bowden, Charles L.

In: Biological Psychiatry, Vol. 39, No. 4, 15.02.1996, p. 278-284.

Research output: Contribution to journalArticle

Petty, F, Rush, AJ, Davis, JM, Calabrese, JR, Kimmel, SE, Kramer, GL, Small, JG, Miller, MJ, Swann, AE, Orsulak, PJ, Blake, ME & Bowden, CL 1996, 'Plasma GABA predicts acute response to divalproex in mania', Biological Psychiatry, vol. 39, no. 4, pp. 278-284. https://doi.org/10.1016/0006-3223(95)00141-7
Petty F, Rush AJ, Davis JM, Calabrese JR, Kimmel SE, Kramer GL et al. Plasma GABA predicts acute response to divalproex in mania. Biological Psychiatry. 1996 Feb 15;39(4):278-284. https://doi.org/10.1016/0006-3223(95)00141-7
Petty, Frederick ; Rush, A. John ; Davis, John M. ; Calabrese, Joseph R. ; Kimmel, Susan E. ; Kramer, Gerald L. ; Small, Joyce G. ; Miller, Marvin J. ; Swann, Alan E. ; Orsulak, Paul J. ; Blake, Molly E. ; Bowden, Charles L. / Plasma GABA predicts acute response to divalproex in mania. In: Biological Psychiatry. 1996 ; Vol. 39, No. 4. pp. 278-284.
@article{585bf749ef114e61a306b1223f20b209,
title = "Plasma GABA predicts acute response to divalproex in mania",
abstract = "Bipolar I, manic phase inpatients were treated with divalproex sodium, lithium, or placebo in a previously reported parallel group multicenter, double-blind, randomized, controlled acute phase treatment trial, Plasma concentrations of gamma aminobutyric acid (GABA) were measured before and after treatment. Higher pretreatment plasma GABA levels were significantly (p = .04) related to a better clinical response to divalproex (n = 19). Pretreatment plasma GABA levels did not correlate with response to either lithium (n = 13) or placebo (n = 31). Following treatment with divalproex sodium, plasma GABA levels decreased significantly (p <.05), compared to placebo. Pretreatment plasma GABA levels were not related to overall severity of manic symptoms. Plasma GABA may predict response to pharmacologic agents acting on the GABA system.",
keywords = "Bipolar disorder, Divalproex, GABA, Lithium, Mania, Response prediction, Valproic acid",
author = "Frederick Petty and Rush, {A. John} and Davis, {John M.} and Calabrese, {Joseph R.} and Kimmel, {Susan E.} and Kramer, {Gerald L.} and Small, {Joyce G.} and Miller, {Marvin J.} and Swann, {Alan E.} and Orsulak, {Paul J.} and Blake, {Molly E.} and Bowden, {Charles L.}",
year = "1996",
month = "2",
day = "15",
doi = "10.1016/0006-3223(95)00141-7",
language = "English (US)",
volume = "39",
pages = "278--284",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Plasma GABA predicts acute response to divalproex in mania

AU - Petty, Frederick

AU - Rush, A. John

AU - Davis, John M.

AU - Calabrese, Joseph R.

AU - Kimmel, Susan E.

AU - Kramer, Gerald L.

AU - Small, Joyce G.

AU - Miller, Marvin J.

AU - Swann, Alan E.

AU - Orsulak, Paul J.

AU - Blake, Molly E.

AU - Bowden, Charles L.

PY - 1996/2/15

Y1 - 1996/2/15

N2 - Bipolar I, manic phase inpatients were treated with divalproex sodium, lithium, or placebo in a previously reported parallel group multicenter, double-blind, randomized, controlled acute phase treatment trial, Plasma concentrations of gamma aminobutyric acid (GABA) were measured before and after treatment. Higher pretreatment plasma GABA levels were significantly (p = .04) related to a better clinical response to divalproex (n = 19). Pretreatment plasma GABA levels did not correlate with response to either lithium (n = 13) or placebo (n = 31). Following treatment with divalproex sodium, plasma GABA levels decreased significantly (p <.05), compared to placebo. Pretreatment plasma GABA levels were not related to overall severity of manic symptoms. Plasma GABA may predict response to pharmacologic agents acting on the GABA system.

AB - Bipolar I, manic phase inpatients were treated with divalproex sodium, lithium, or placebo in a previously reported parallel group multicenter, double-blind, randomized, controlled acute phase treatment trial, Plasma concentrations of gamma aminobutyric acid (GABA) were measured before and after treatment. Higher pretreatment plasma GABA levels were significantly (p = .04) related to a better clinical response to divalproex (n = 19). Pretreatment plasma GABA levels did not correlate with response to either lithium (n = 13) or placebo (n = 31). Following treatment with divalproex sodium, plasma GABA levels decreased significantly (p <.05), compared to placebo. Pretreatment plasma GABA levels were not related to overall severity of manic symptoms. Plasma GABA may predict response to pharmacologic agents acting on the GABA system.

KW - Bipolar disorder

KW - Divalproex

KW - GABA

KW - Lithium

KW - Mania

KW - Response prediction

KW - Valproic acid

UR - http://www.scopus.com/inward/record.url?scp=9044227617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9044227617&partnerID=8YFLogxK

U2 - 10.1016/0006-3223(95)00141-7

DO - 10.1016/0006-3223(95)00141-7

M3 - Article

VL - 39

SP - 278

EP - 284

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 4

ER -